PAPER Teyssou E, Takeda T, Lebon V, Boillée S, Doukouré B, Bataillon G, Sazdovitch V, Cazeneuve C, Meininger V, LeGuern E, Salachas F, Seilhean D, Millecamps S
SEARCH RESULTS
330988 RESULTS
PAPER Giacomello M, Oliveros JC, Naranjo JR, Carafoli E
Neuronal Ca(2+) dyshomeostasis in Huntington disease.
Prion. 2013 Jan-Feb;7(1):76-84. PubMed: 23324594PAPER Alies B, Hureau C, Faller P
The role of metal ions in amyloid formation: general principles from model peptides.
Metallomics. 2013 Mar;5(3):183-92. PubMed: 23416948PAPER Thomas B, Matson S, Chopra V, Sun L, Sharma S, Hersch S, Diana Rosas H, Scherzer C, Ferrante R, Matson W
A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.
Anal Biochem. 2013 May 15;436(2):112-20. PubMed: 23416183PAPER Zheng Z, Shemmassian S, Wijekoon C, Kim W, Bookheimer SY, Pouratian N
DTI correlates of distinct cognitive impairments in Parkinson's disease.
Hum Brain Mapp. 2013 Feb 18; PubMed: 23417856PAPER Mallat J, Barrailler S, Lemyze M, Pepy F, Gasan G, Tronchon L, Thevenin D
Use of sodium-chloride difference and corrected anion gap as surrogates of Stewart variables in critically ill patients.
PLoS One. 2013;8(2):e56635. PubMed: 23418590PAPER Yamaguchi T, Matsuzaki K, Hoshino M
Interaction between soluble Aβ-(1-40) monomer and Aβ-(1-42) fibrils probed by paramagnetic relaxation enhancement.
FEBS Lett. 2013 Mar 18;587(6):620-4. PubMed: 23416305PAPER Hawkes CA, Gatherer M, Sharp MM, Dorr A, Yuen HM, Kalaria R, Weller RO, Carare RO
Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain.
Aging Cell. 2013 Apr;12(2):224-36. PubMed: 23413811PAPER Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S, Glatzel M
Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
FEBS J. 2013 Feb 18; PubMed: 23413979PAPER Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A
Olive-Oil-Derived Oleocanthal Enhances β-Amyloid Clearance as a Potential Neuroprotective Mechanism against Alzheimer's Disease: In Vitro and in Vivo Studies.
ACS Chem Neurosci. 2013 Feb 25; PubMed: 23414128PAPER Yoon SY, Choi JU, Cho MH, Yang KM, Ha H, Chung IJ, Cho GS, Kim DH
α-secretase cleaved APP accumulates in cholinergic dystrophic neurites in normal, aged hippocampus.
Neuropathol Appl Neurobiol. 2013 Feb 18; PubMed: 23414335PAPER Rojas GJ, Villar V, Iturry M, Harris P, Serrano CM, Herrera JA, Allegri RF
Efficacy of a cognitive intervention program in patients with mild cognitive impairment.
Int Psychogeriatr. 2013 May;25(5):825-31. PubMed: 23414646PAPER Yu F
Improving recruitment, retention, and adherence to 6-month cycling in Alzheimer's disease.
Geriatr Nurs. 2013 Feb 12; PubMed: 23414638PAPER Gao FQ, Pettersen JA, Bocti C, Nestor SM, Kiss A, Black SE
Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
Neurobiol Aging. 2013 Jul;34(7):1807-14. PubMed: 23414670PAPER Miller BL
The C9ORF72 mutation brings more answers and more questions.
Alzheimers Res Ther. 2013 Feb 18;5(1):7. PubMed: 23414702Current Filters
No filters selected